RODRIGO TOBAR: Open Payments
NPI 1316014566 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 32 payments from 8 companies in 2025. Trend: 2023 $853 · 2024 $793 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $313 |
| Lilly USA, LLC | 3 | $151 |
| AstraZeneca Pharmaceuticals LP | 8 | $144 |
| PFIZER INC. | 3 | $57 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Astellas Pharma US Inc | 1 | $29 |
| Abbott Laboratories | 1 | $24 |
| Exact Sciences Corporation | 1 | $18 |
Products named: Ozempic, ZEPBOUND, AIRSUPRA, Rybelsus, PREVNAR 20, TRELEGY ELLIPTA, Saxenda, MOUNJARO.
Industry payments across MI — which companies pay providers there.
